Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

OCGN

Ocugen Inc

May 26 • 11:25AM ET

1.38

+0.04 2.99 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RGNX OCUL EDIT INO NVAX

| Held by: VTI XBI VXF KOMP VHT ITOT IDNA MOON LABU ONEQ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.23	Insider Own	2.71%	Shs Outstand	338.32M	Perf Week	2.99%
Market Cap	467.16M	Forward P/E	165.67	EPS next Y	0.01	Insider Trans	0.00%	Shs Float	329.34M	Perf Month	-16.87%
Enterprise Value	468.60M	PEG	-	EPS next Q	-0.05	Inst Own	33.79%	Short Float	21.16%	Perf Quarter	-22.47%
Income	-71.67M	P/S	104.74	EPS this Y	3.11%	Inst Trans	23.25%	Short Ratio	7.83	Perf Half Y	24.32%
Sales	4.46M	P/B	80.42	EPS next Y	103.74%	ROA	-118.11%	Short Interest	69.67M	Perf YTD	2.22%
Book/sh	0.02	P/C	14.66	EPS next 5Y	-	ROE	-660.00%	52W High	2.72 -49.36%	Perf Year	48.26%
Cash/sh	0.09	P/FCF	-	EPS past 3/5Y	17.64% 5.89%	ROIC	-215.58%	52W Low	0.80 72.50%	Perf 3Y	198.06%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	21.05% 152.94%	Gross Margin	44.48%	Volatility	5.14% 5.57%	Perf 5Y	-81.98%
Dividend TTM	-	EV/Sales	105.07	EPS Y/Y TTM	-23.97%	Oper. Margin	-1483.85%	ATR (14)	0.10	Perf 10Y	-98.83%
Dividend Ex-Date	-	Quick Ratio	1.86	Sales Y/Y TTM	-1.26%	Profit Margin	-1605.22%	RSI (14)	38.33	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.86	EPS Q/Q	-11.41%	SMA20	-7.86%	Beta	2.23	Target Price	11.57
Payout	-	Debt/Eq	5.74	Sales Q/Q	3.51%	SMA50	-20.72%	Rel Volume	0.75	Prev Close	1.34
Employees	116	LT Debt/Eq	4.73	Earnings	May 05 BMO	SMA200	-8.57%	Avg Volume	8.89M	Price	1.38
IPO	Dec 03, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-16.73% 266.92%	Trades		Volume	2,213,001	Change	2.99%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)